137 related articles for article (PubMed ID: 38459811)
1. Epstein-Barr virus associated colitis in kidney transplant patients: a case series.
Brás AC; Querido S; Mascarenhas A; Mendes R; Verissimo R; Chagas C; Weigert A
Infect Dis (Lond); 2024 May; 56(5):410-415. PubMed ID: 38459811
[TBL] [Abstract][Full Text] [Related]
2. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Zhang H; Zhao S; Cao Z
Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
[TBL] [Abstract][Full Text] [Related]
3. Primary Intestinal Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease.
Wang Z; Zhang W; Luo C; Zhu M; Zhen Y; Mu J; Zhang Y; Hu R; Wang Y; Wen Z; Ouyang Q; Xiao S; Zhang H
J Crohns Colitis; 2018 Jul; 12(8):896-904. PubMed ID: 29635312
[TBL] [Abstract][Full Text] [Related]
4. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.
Goetgebuer RL; van der Woude CJ; de Ridder L; Doukas M; de Vries AC
Int J Colorectal Dis; 2019 May; 34(5):923-926. PubMed ID: 30739187
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
6. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal complications after kidney transplantation.
Gioco R; Corona D; Ekser B; Puzzo L; Inserra G; Pinto F; Schipa C; Privitera F; Veroux P; Veroux M
World J Gastroenterol; 2020 Oct; 26(38):5797-5811. PubMed ID: 33132635
[TBL] [Abstract][Full Text] [Related]
8. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
11. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
12. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
Wu S; He C; Tang TY; Li YQ
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus associated CNS lymphoproliferative disorder after long-term immunosuppression.
Lee A; Bridges LR; Lloyd M; Barker R; Wren DR; Galtrey CM
Pract Neurol; 2020 Feb; 20(1):83-86. PubMed ID: 31467148
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection in adult renal transplant recipients.
Morton M; Coupes B; Roberts SA; Johnson SL; Klapper PE; Vallely PJ; Picton ML
Am J Transplant; 2014 Jul; 14(7):1619-29. PubMed ID: 24815922
[TBL] [Abstract][Full Text] [Related]
15. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
16. Retransplantation after post transplant lymphoproliferative disorder: overcoming the obstacles!
Prasad P; Khullar D; Gupta N; Grover R; Chhabra G; Gandhi KR; Gupta S; Bagai S
CEN Case Rep; 2020 Aug; 9(3):200-203. PubMed ID: 32016786
[TBL] [Abstract][Full Text] [Related]
17. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B;
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847
[TBL] [Abstract][Full Text] [Related]
18. Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation.
Adani GL; Baccarani U; Lorenzin D; Bresadola V; Currò G; Sainz M; Gropuzzo M; Montanaro D; Tulissi P; Risaliti A; Bresadola F
Tumori; 2006; 92(3):219-21. PubMed ID: 16869239
[TBL] [Abstract][Full Text] [Related]
19. Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.
Birkeland SA; Andersen HK; Hamilton-Dutoit SJ
Transplantation; 1999 May; 67(9):1209-14. PubMed ID: 10342310
[TBL] [Abstract][Full Text] [Related]
20. Spleen-Restricted Posttransplant Lymphoproliferative Disorder in the First Year After Kidney Transplant - A Case Report.
Rodrigues AC; Fernandes S; Bustorff M; Nunes AT; Ferreira I; Tavares I; Rocha A; Carneiro A; Sampaio SN
Transplant Proc; 2022; 54(6):1624-1626. PubMed ID: 35487782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
